DCLK1 and cardiomyopathy: Our study provides extensive proof that macrophage-specific DCLK1 has a deleterious impact on obesity-associated cardiomyopathy by inducing RIP2/TAK1 activation and inflammatory responses in macrophages, which subsequently promotes cardiac hypertrophy and fibrosis.